Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of non-small-cell carcinoma of the lung
Patients with locally advanced disease or metastatic disease, candidates to surgery after evaluation by oncologist and thoracic surgeon
Tumour with possibility of curative surgery
At least one uni-dimensionally measurable lesion
Adequate pulmonary function to perform the planned surgical resection
You may not be if
Active infection (at the investigator's discretion)
Pregnancy or breast-feeding
Serious concomitant illness at the investigator's discretion
Previous diagnosis of malignant disease
They have received treatment during the last 30 days with a drug, other than the study drug, that has not received regulatory approval for any indication at the time of their entry in the study
Clareo Health | Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer
